{
    "2019-10-24": [
        [
            {
                "time": "",
                "original_text": "医疗器械企业收入将破万亿元，北上深居创新项目申请前三",
                "features": {
                    "keywords": [
                        "医疗器械",
                        "收入",
                        "万亿元",
                        "北上深",
                        "创新项目"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "债券融资成本大比拼！这9家民企可与央企论高低",
                "features": {
                    "keywords": [
                        "债券融资",
                        "成本",
                        "民企",
                        "央企"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【民生医药】医药生物2019年三季报总结：基本面进入值得期待的新周期",
                "features": {
                    "keywords": [
                        "医药生物",
                        "三季报",
                        "基本面",
                        "新周期"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "登陆港股后又谋科创板上市：君实生物的资本大局",
                "features": {
                    "keywords": [
                        "港股",
                        "科创板",
                        "君实生物",
                        "资本"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}